What we do Jubilant Ingrevia Ltd is a global integrated Life Sciences and Specialty Chemicals company serving pharmaceutical, nutrition, agrochemical, consumer, semiconductor, and industrial sectors with innovative, cost-effective solutions. |
Founded in 2,019 |
Market share Among top global players in Pyridine & Picolines, Vitamin B3, Acetic Anhydride; largest producer of Niacinamide; leading supplier in India for ethanol blending. |
Problem solved Provides customized, high-quality life science products and CDMO services addressing pharma and agrochemical manufacturing needs with innovation and efficiency. |
Top clients or who we serve Serves 1500+ customers globally including pharmaceutical, nutrition, agrochemical, industrial sectors; B2B focus across 60+ countries. |
Key management CEO & MD: Deepak Jain (20+ years), Chairman: Shyam S Bhartia, Co-Chairman: Hari S Bhartia; leadership with deep industry expertise. |
Our journey and innovations Founded from Jubilant Bhartia Group legacy; evolved from acetyls to specialty chemicals and nutrition; strong R&D with 150 scientists; first Indian chemical firm in WEF Global Lighthouse Network for 4IR. |
Where we operate Operates across India with 5 manufacturing facilities; exports to US, Europe, China, Middle East, Southeast Asia, and other regions. |
Top products or what we offer Specialty chemicals including pyridine derivatives, nutrition solutions like Vitamin B3 and Choline, chemical intermediates like acetyl products, and fast-growing CDMO services. |
Top brands Niacinamide (globally #1), Vitamin B3 and B4 (top two globally), Acetic Anhydride (globally #2), Phytoshield herbal product range. |
Raw materials needed Basic chemicals for pyridine derivatives, acetyls, vitamins; ethanol and bio-based feedstocks for green initiatives. |
Raw materials supplier Includes global chemical suppliers and renewable energy partners like O2 Power SG PTE. Ltd. |
Recurring vs cyclical contribution Revenue driven by a mix of recurring formulation sales and cyclical custom manufacturing & specialty chemical contracts. |
Our industry position Strong competitive position globally in specialty chemicals and nutrition; recognized for sustainability and operational excellence. |
Financial highlights FY25 Consolidated revenue ₹4,177 crore; PAT ₹251 crore; EBITDA margin steady at ~13%; healthy growth in specialty chemicals and nutrition segments. |
Geographical revenue split 56% India, 24% Europe, 8% North America, 12% Rest of world including China and Southeast Asia. |
Order book Strong CDMO order pipeline with 100+ active molecules and ₹3,500 crore peak revenue potential. |
Whats driving growth Growth driven by volume increases in specialty chemicals and nutrition, expansion in CDMO, green energy adoption, and operational efficiencies. |
Our future plans Commissioning new multipurpose plants, expanding CDMO capabilities, increasing renewable energy usage, and enhancing R&D pipeline. |
Our green promise Committed to sustainability with 34% renewable power usage; certifications including Responsible Care, ISO, and global ESG rankings. |
Our people and values Workforce of 2,300+ employees; certified as Top 50 Best Workplaces in Manufacturing; emphasis on safety, inclusion, and continuous learning. |
Key challenges ahead Fluctuating raw material prices, global pricing pressures, geopolitical uncertainties, and managing supply-demand imbalances. |
Interesting facts First Indian chemical company in WEF Global Lighthouse Network; holds leadership in multiple vitamin B products; recognized repeatedly for operational excellence. |
Risks and strategy Mitigates risks via robust governance, risk management committees, diversification, technology adoption, and sustainability initiatives. |
